Safety and Usefulness of Cryobiopsy and Stamp Cytology for the Diagnosis of Peripheral Pulmonary Lesions
Tatsuya Imabayashi, Junji Uchino, Akihiro Yoshimura, Yusuke Chihara, Nobuyo Tamiya, Yoshiko Kaneko, Tadaaki Yamada, Koichi Takayama, Tatsuya Imabayashi, Junji Uchino, Akihiro Yoshimura, Yusuke Chihara, Nobuyo Tamiya, Yoshiko Kaneko, Tadaaki Yamada, Koichi Takayama
Abstract
Reports on the use of cryobiopsy (CB) for lung cancer diagnosis are limited. The aims of the present study were to evaluate the safety and usefulness of CB using radial endobronchial ultrasonography, without a guide sheath, for the diagnosis of peripheral pulmonary lesions and determine the utility of stamp cytology, an on-site diagnostic technique for determining tumor inclusion in CB samples. We retrospectively analyzed data for 35 patients (36 lesions) with suspected peripheral lung cancer who underwent CB between August 2017 and February 2019 at our medical facility. The diagnostic yield, incidence of complications, and the utility of stamp cytology for diagnosis were investigated. The diagnostic yield of CB was 86.1% (31/36) with histological diagnosis, and 80.5% (29/36) with diagnosis using stamp cytology; the overall yield was 91.6% (33/36). Pneumothorax requiring thoracic drainage occurred in two patients, both of whom had lesions contacting the pleura. Grade 2 and grade 1 bleeding occurred in one and 25 patients, respectively. CB enables the collection of very large, nearly intact tissue samples, thus resulting in an improvement in the true diagnosis rate and facilitating the measurement of multiple biomarkers as well as rapid histological diagnosis.
Keywords: bronchoscopy; cell biology; cryobiopsy; lung cancer; ultrasonography.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
- Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer. 2003;3:733–744. doi: 10.1038/nrc1190.
- Planchard D., Kim T.M., Mazieres J., Quoix E., Riely G., Barlesi F., Souquet P.J., Smit E.F., Groen H.J., Kelly R.J., et al. Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: A single-arm, multicentre, open-label, phase 2 trial. Lancet Oncol. 2016;17:642–650. doi: 10.1016/S1470-2045(16)00077-2.
- Planchard D., Besse B., Groen H.J.M., Souquet P.J., Quoix E., Baik C.S., Barlesi F., Kim T.M., Mazieres J., Novello S., et al. Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: An open-label, multicentre phase 2 trial. Lancet Oncol. 2016;17:984–993. doi: 10.1016/S1470-2045(16)30146-2.
- Planchard D., Smit E.F., Groen H.J.M., Mazieres J., Besse B., Helland Å., Giannone V., D’Amelio A.M., Jr., Zhang P., Mookerjee B., et al. Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: An open-label, phase 2 trial. Lancet Oncol. 2017;18:1307–1316. doi: 10.1016/S1470-2045(17)30679-4.
- Mathur P.N., Wolf K.M., Busk M.F., Briete W.M., Datzman M. Fiberoptic bronchoscopic cryotherapy in the management of tracheobronchial obstruction. Chest. 1996;110:718–723. doi: 10.1378/chest.110.3.718.
- Ganganah O., Guo S.L., Chiniah M., Li Y.S. Efficacy and safety of cryobiopsy versus forceps biopsy for interstitial lung diseases and lung tumours: A systematic review and meta-analysis. Respirology. 2016;21:834–841. doi: 10.1111/resp.12770.
- Lentz R.J., Argento A.C., Colby T.V., Rickman O.B., Maldonado F. Transbronchial cryobiopsy for diffuse parenchymal lung disease: A state-of-the-art review of procedural techniques, current evidence, and future challenges. J. Thorac. Dis. 2017;9:2186–2203. doi: 10.21037/jtd.2017.06.96.
- Hetzel J., Maldonado F., Ravaglia C., Wells A.U., Colby T.V., Tomassetti S., Ryu J.H., Fruchter O., Piciucchi S., Dubini A., et al. Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure. Respiration. 2018;95:188–200. doi: 10.1159/000484055.
- Schumann C., Hetzel J., Babiak A.J., Merk T., Wibmer T., Moller P., Lepper P.M., Hetzel M. Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions. J. Thorac. Cardiovasc. Surg. 2010;140:417–421. doi: 10.1016/j.jtcvs.2009.12.028.
- Aktas Z., Gunay E., Hoca N.T., Yilmaz A., Demirag F., Gunay S., Sipit T., Kurt E.B. Endobronchial cryobiopsy or forceps biopsy for lung cancer diagnosis. Ann. Thorac. Med. 2010;5:242–246.
- Hetzel J., Eberhardt R., Herth F.J.F., Petermann C., Reichle G., Freitag L., Dobbertin I., Franke K.J., Stanzel F., Beyer T., et al. Cryobiopsy increases the diagnostic yield of endobronchial biopsy: A multicentre trial. Eur. Respir. J. 2012;39:685–690. doi: 10.1183/09031936.00033011.
- Jabari H., Sami R., Fakhri M., Kiani A. Different protocols for cryobiopsy versus forceps biopsy in diagnosis of patients with endobronchial tumors. Pneumologia. 2012;61:230–233.
- Rubio E.R., Le S.R., Whatley R.E., Boyd M.B. Cryobiopsy: Should this be used in place of endobronchial forceps biopsies? Biomed. Res. Int. 2013;2013:730574. doi: 10.1155/2013/730574.
- Segmen F., Aktas Z., Özturk A., Kizilgöz D., Yilmaz A., Alici I.O., Demirağ F., Pehlivanoğlu P. How many samples would be optimal for endobronchial cryobiopsy? Surg. Endosc. 2017;31:1219–1224. doi: 10.1007/s00464-016-5095-3.
- Schuhmann M., Bostanci K., Bugalho A., Warth A., Schnabel P.A., Herth F.J., Eberhardt R. Endobronchial ultrasound-guided cryobiopsies in peripheral pulmonary lesions: A feasibility study. Eur. Respir. J. 2014;43:233–239. doi: 10.1183/09031936.00011313.
- Herath S., Yap E. Novel hybrid cryo-radial method: An emerging alternative to CT-guided biopsy in suspected lung cancer. A prospective case series and description of technique. Respirol. Case Rep. 2017;6:e00287. doi: 10.1002/rcr2.287.
- Arimura K., Tagaya E., Akagawa H., Nagashima Y., Shimizu S., Atsumi Y., Sato A., Kanzaki M., Kondo M., Takeyama K., et al. Cryobiopsy with endobronchial ultrasonography using a guide sheath for peripheral pulmonary lesions and DNA analysis by next generation sequencing and rapid on-site evaluation. Respir. Investig. 2018 doi: 10.1016/j.resinv.2018.10.006.
- Taton O., Bondue B., Gevenois P.A., Remmelink M., Leduc D. Diagnostic Yield of Combined Pulmonary Cryobiopsies and Electromagnetic Navigation in Small Pulmonary Nodules. Pulm. Med. 2018 doi: 10.1155/2018/6032974.
- Echevarria-Uraga J.J., Pèerez-Izquierdo J., Garcìa-Garai N., Gòmez-Jiménez E., Aramburu-Ojembarrena A., Tena-Tudanca L., Miguélez-Vidales J.L., Capelastequi-Saiz A. Usefulness of an angioplasty balloon as selective bronchial blockade device after transbronchial cryobiopsy. Respirology. 2016;21:1094–1099. doi: 10.1111/resp.12827.
- Yarmus L.B., Semaan R.W., Arias S.A., Feller-Kopman D., Ortiz R., Bösmüller H., Illei P.B., Frimpong B.O., Oakjones-Burgess K., Lee H.J. A Randomized Controlled Trial of a Novel Sheath Cryoprobe for Bronchoscopic Lung Biopsy in a Porcine Model. Chest. 2016;150:329–336. doi: 10.1016/j.chest.2016.01.018.
- Kawaraya M., Gemba K., Ueoka H., Nishii K., Kiura K., Kodani T., Tabata M., Shibayama T., Kitajima T., Tanimoto M. Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancer. Br. J. Cancer. 2003;89:1885–1888. doi: 10.1038/sj.bjc.6601368.
- Berim I.G., Saeed A.I., Awab A., Highley A., Colanta A., Chaudry F. Radial Probe Ultrasound-Guided Cryobiopsy. J. Bronchol. Interv. Pulmonol. 2017;24:170–173. doi: 10.1097/LBR.0000000000000368.
Source: PubMed